Skip to main content
Erschienen in: The Cerebellum 4/2012

01.12.2012 | Original Paper

Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)

verfasst von: Conceição Bettencourt, Mafalda Raposo, Nadiya Kazachkova, Cristina Santos, Teresa Kay, João Vasconcelos, Patrícia Maciel, Karina C. Donis, Maria Luiza Saraiva-Pereira, Laura B. Jardim, Jorge Sequeiros, Jácome Bruges-Armas, Manuela Lima

Erschienen in: The Cerebellum | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Machado–Joseph disease (MJD) is a late-onset autosomal dominant neurodegenerative disorder, which is caused by a coding (CAG)n expansion in the ATXN3 gene (14q32.1). The number of CAG repeats in the expanded alleles accounts only for 50 to 75 % of onset variance, the remaining variation being dependent on other factors. Differential allelic expression of ATXN3 could contribute to the explanation of different ages at onset in patients displaying similar CAG repeat sizes. Variation in 5′ regulatory regions of the ATXN3 gene may have the potential to influence expression levels and, ultimately, modulate the MJD phenotype. The main goal of this work was to analyze the extent of sequence variation upstream of the ATXN3 start codon. A fragment containing the core promoter and the 5′ untranslated region (UTR) was sequenced and analyzed in 186 patients and 59 controls (490 chromosomes). In the core promoter, no polymorphisms were observed. In the 5′ UTR, only one SNP (rs3814834) was found, but no improvements on the explanation of onset variance were observed, when adding its allelic state in a linear model. Accordingly, in silico analysis predicted that this SNP lays in a nonconserved position for CMYB binding. Therefore, no functional effect could be predicted for this variant.
Literatur
1.
Zurück zum Zitat Carvalho DR, La Rocque-Ferreira A, Rizzo IM, Imamura EU, Speck-Martins CE. Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol. 2008;38(4):296–9.PubMedCrossRef Carvalho DR, La Rocque-Ferreira A, Rizzo IM, Imamura EU, Speck-Martins CE. Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol. 2008;38(4):296–9.PubMedCrossRef
2.
Zurück zum Zitat Coutinho P. Doença de Machado-Joseph: Tentativa de definição: PhD Dissertation, Instituto de Ciências Biomédicas Abel Salazar, Porto; 1992. Coutinho P. Doença de Machado-Joseph: Tentativa de definição: PhD Dissertation, Instituto de Ciências Biomédicas Abel Salazar, Porto; 1992.
3.
Zurück zum Zitat Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado–Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8(3):221–8.PubMedCrossRef Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado–Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8(3):221–8.PubMedCrossRef
4.
Zurück zum Zitat Ichikawa Y, Goto J, Hattori M, et al. The genomic structure and expression of MJD, the Machado–Joseph disease gene. J Hum Genet. 2001;46(7):413–22.PubMedCrossRef Ichikawa Y, Goto J, Hattori M, et al. The genomic structure and expression of MJD, the Machado–Joseph disease gene. J Hum Genet. 2001;46(7):413–22.PubMedCrossRef
5.
Zurück zum Zitat Maciel P, Costa MC, Ferro A, et al. Improvement in the molecular diagnosis of Machado–Joseph disease. Arch Neurol. 2001;58(11):1821–7.PubMedCrossRef Maciel P, Costa MC, Ferro A, et al. Improvement in the molecular diagnosis of Machado–Joseph disease. Arch Neurol. 2001;58(11):1821–7.PubMedCrossRef
6.
Zurück zum Zitat Bettencourt C, Lima M. Machado–Joseph disease: from first descriptions to new perspectives. Orphanet J Rare Dis. 2011;6:35.PubMedCrossRef Bettencourt C, Lima M. Machado–Joseph disease: from first descriptions to new perspectives. Orphanet J Rare Dis. 2011;6:35.PubMedCrossRef
7.
Zurück zum Zitat Maciel P, Gaspar C, DeStefano AL, et al. Correlation between CAG repeat length and clinical features in Machado–Joseph disease. Am J Hum Genet. 1995;57(1):54–61.PubMed Maciel P, Gaspar C, DeStefano AL, et al. Correlation between CAG repeat length and clinical features in Machado–Joseph disease. Am J Hum Genet. 1995;57(1):54–61.PubMed
8.
Zurück zum Zitat Bettencourt C, Santos C, Montiel R, et al. The (CAG)n tract of Machado–Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls. Eur J Hum Genet. 2010;18(5):621–3.PubMedCrossRef Bettencourt C, Santos C, Montiel R, et al. The (CAG)n tract of Machado–Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls. Eur J Hum Genet. 2010;18(5):621–3.PubMedCrossRef
9.
Zurück zum Zitat Bettencourt C, Raposo M, Kazachkova N, et al. The ε2 allele of APOE increases the risk of earlier age-at-onset in Machado–Joseph Disease (MJD/SCA3). Arch Neurol. 2011;68(12):1580–3.PubMedCrossRef Bettencourt C, Raposo M, Kazachkova N, et al. The ε2 allele of APOE increases the risk of earlier age-at-onset in Machado–Joseph Disease (MJD/SCA3). Arch Neurol. 2011;68(12):1580–3.PubMedCrossRef
10.
Zurück zum Zitat Emmel VE, Donis KC, Gheno TC, et al. GRIK2, IL1B, NEDD8 and NEDD9 genes may act as modifiers of the Machado Joseph Disease/SCA 3 phenotype [Abs]. In: 12th ICHG. Montreal; 2011. p 498. Emmel VE, Donis KC, Gheno TC, et al. GRIK2, IL1B, NEDD8 and NEDD9 genes may act as modifiers of the Machado Joseph Disease/SCA 3 phenotype [Abs]. In: 12th ICHG. Montreal; 2011. p 498.
11.
Zurück zum Zitat Bettencourt C, Santos C, Montiel R, et al. Increased transcript diversity: novel splicing variants of Machado–Joseph Disease gene (ATXN3). Neurogenetics. 2010;11(2):193–202.PubMedCrossRef Bettencourt C, Santos C, Montiel R, et al. Increased transcript diversity: novel splicing variants of Machado–Joseph Disease gene (ATXN3). Neurogenetics. 2010;11(2):193–202.PubMedCrossRef
12.
Zurück zum Zitat Bilen J, Bonini NM. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet. 2005;39:153–71.PubMedCrossRef Bilen J, Bonini NM. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet. 2005;39:153–71.PubMedCrossRef
13.
Zurück zum Zitat Goti D, Katzen SM, Mez J, et al. A mutant ataxin-3 putative-cleavage fragment in brains of Machado–Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci. 2004;24(45):10266–79.PubMedCrossRef Goti D, Katzen SM, Mez J, et al. A mutant ataxin-3 putative-cleavage fragment in brains of Machado–Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci. 2004;24(45):10266–79.PubMedCrossRef
14.
Zurück zum Zitat Lerer I, Merims D, Abeliovich D, Zlotogora J, Gadoth N. Machado–Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Hum Genet. 1996;4(1):3–7.PubMed Lerer I, Merims D, Abeliovich D, Zlotogora J, Gadoth N. Machado–Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Hum Genet. 1996;4(1):3–7.PubMed
15.
Zurück zum Zitat Sobue G, Doyu M, Nakao N, et al. Homozygosity for Machado–Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry. 1996;60(3):354–6.PubMedCrossRef Sobue G, Doyu M, Nakao N, et al. Homozygosity for Machado–Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry. 1996;60(3):354–6.PubMedCrossRef
16.
Zurück zum Zitat Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol. 2005;207(2 Suppl):84–90.PubMedCrossRef Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol. 2005;207(2 Suppl):84–90.PubMedCrossRef
17.
Zurück zum Zitat Chatterjee S, Pal JK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell. 2009;101(5):251–62.PubMedCrossRef Chatterjee S, Pal JK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell. 2009;101(5):251–62.PubMedCrossRef
18.
Zurück zum Zitat Schmitt I, Evert BO, Khazneh H, Klockgether T, Wuellner U. The human MJD gene: genomic structure and functional characterization of the promoter region. Gene. 2003;314:81–8.PubMedCrossRef Schmitt I, Evert BO, Khazneh H, Klockgether T, Wuellner U. The human MJD gene: genomic structure and functional characterization of the promoter region. Gene. 2003;314:81–8.PubMedCrossRef
19.
Zurück zum Zitat Bettencourt C, Fialho RN, Santos C, et al. Segregation distortion of wild-type alleles at the Machado–Joseph disease locus: a study in normal families from the Azores islands (Portugal). J Hum Genet. 2008;53(4):333–9.PubMedCrossRef Bettencourt C, Fialho RN, Santos C, et al. Segregation distortion of wild-type alleles at the Machado–Joseph disease locus: a study in normal families from the Azores islands (Portugal). J Hum Genet. 2008;53(4):333–9.PubMedCrossRef
20.
Zurück zum Zitat Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 1999;41:95–8. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 1999;41:95–8.
21.
Zurück zum Zitat Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics. 1999;15(7–8):622–30.PubMedCrossRef Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics. 1999;15(7–8):622–30.PubMedCrossRef
22.
Zurück zum Zitat Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 2003;31(13):3576–9.PubMedCrossRef Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 2003;31(13):3576–9.PubMedCrossRef
23.
Zurück zum Zitat Schneider S, Roessli D, Excoffier L. Arlequin: a software for population genetics data analysis, version 2.000. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Switzerland 2000. Schneider S, Roessli D, Excoffier L. Arlequin: a software for population genetics data analysis, version 2.000. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Switzerland 2000.
24.
Zurück zum Zitat Inc. S. SPSS for Windows: Release 15.0. In. Chicago: SPSS Inc.; 2006. Inc. S. SPSS for Windows: Release 15.0. In. Chicago: SPSS Inc.; 2006.
25.
Zurück zum Zitat do Carmo Costa M, Gomes-da-Silva J, Miranda CJ, Sequeiros J, Santos MM, Maciel P. Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado–Joseph disease (MJD) gene. Genomics. 2004;84(2):361–73.CrossRef do Carmo Costa M, Gomes-da-Silva J, Miranda CJ, Sequeiros J, Santos MM, Maciel P. Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado–Joseph disease (MJD) gene. Genomics. 2004;84(2):361–73.CrossRef
26.
Zurück zum Zitat Theuns J, Del-Favero J, Dermaut B, et al. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer’s disease and variable expression. Hum Mol Genet. 2000;9(3):325–31.PubMedCrossRef Theuns J, Del-Favero J, Dermaut B, et al. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer’s disease and variable expression. Hum Mol Genet. 2000;9(3):325–31.PubMedCrossRef
27.
Zurück zum Zitat Sutherland G, Mellick G, Sue C, et al. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson’s disease. Neurosci Lett. 2007;414(2):170–3.PubMedCrossRef Sutherland G, Mellick G, Sue C, et al. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson’s disease. Neurosci Lett. 2007;414(2):170–3.PubMedCrossRef
28.
Zurück zum Zitat Coles R, Leggo J, Rubinsztein DC. Analysis of the 5′ upstream sequence of the Huntington’s disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD. J Med Genet. 1997;34(5):371–4.PubMedCrossRef Coles R, Leggo J, Rubinsztein DC. Analysis of the 5′ upstream sequence of the Huntington’s disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD. J Med Genet. 1997;34(5):371–4.PubMedCrossRef
29.
Zurück zum Zitat Byars JA, Beglinger LJ, Moser DJ, Gonzalez-Alegre P, Nopoulos P. Substance abuse may be a risk factor for earlier onset of Huntington disease. J Neurol 2012 (in press). Byars JA, Beglinger LJ, Moser DJ, Gonzalez-Alegre P, Nopoulos P. Substance abuse may be a risk factor for earlier onset of Huntington disease. J Neurol 2012 (in press).
30.
Zurück zum Zitat Friedman JH, Trieschmann ME, Myers RH, Fernandez HH. Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol. 2005;62(6):995–7.PubMedCrossRef Friedman JH, Trieschmann ME, Myers RH, Fernandez HH. Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol. 2005;62(6):995–7.PubMedCrossRef
31.
Zurück zum Zitat Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci U S A. 2004;101(10):3498–503.PubMedCrossRef Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci U S A. 2004;101(10):3498–503.PubMedCrossRef
Metadaten
Titel
Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)
verfasst von
Conceição Bettencourt
Mafalda Raposo
Nadiya Kazachkova
Cristina Santos
Teresa Kay
João Vasconcelos
Patrícia Maciel
Karina C. Donis
Maria Luiza Saraiva-Pereira
Laura B. Jardim
Jorge Sequeiros
Jácome Bruges-Armas
Manuela Lima
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
The Cerebellum / Ausgabe 4/2012
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-012-0373-7

Weitere Artikel der Ausgabe 4/2012

The Cerebellum 4/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.